BeStock  
Markets › Compare › GLAPY vs KNSA

GLAPY vs KNSA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
GLAPY · GLANBIA SPONS ADR EACH REP 5 COM EUR0.06$114.25 ▼ 7.17%
KNSA · Kiniksa Pharmaceuticals International$76.31 ▲ 0.69%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

90122155187219Oct 7, '25Apr 7, '26Oct 2, '26
  • GLAPY +58.7%
  • KNSA +98.8%

Head to head

MetricGLAPYKNSA
Price$114.25$76.31
Change today▼ 7.17%▲ 0.69%
Market cap$5.95B$5.95B
Return, 3 months-19.2%+13.4%
Return, year to date+35.3%+85.0%
Return, 1 year+47.4%+99.3%
P/E (TTM)23.677.1
P/B2.99.1
P/E percentile vs own 5y––
Dividend yield2.11%–
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)1750
30-day volatility9.5%25.7%
Max drawdown, 1 year-13.5%-21.1%
Trend readLeaning bullishLeaning bearish
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • KNSA is the largest of the group by market value.
  • KNSA has returned the most over the past year.
  • GLAPY carries the lowest trailing P/E.
  • GLAPY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top